Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Novavax Inc (NQ: NVAX )

4.610 -0.150 (-3.15%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,270,515
Open 4.940
Bid (Size) 4.590 (1)
Ask (Size) 4.610 (6)
Prev. Close 4.760
Today's Range 4.475 - 4.940
52wk Range 3.532 - 11.36
Shares Outstanding 74,484,166
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Shah Capital Launches Campaign Urging Stockholders to Vote AGAINST the Re-Election of All of Novavax’s Directors Up for Election at its 2024 Annual Meeting
From Shah Capital
Via GlobeNewswire
Pfizer Finds a Foothold After a Solid Q1 2024 Earnings Report
After a painful two-year selloff, Pfizer shareholders may have finally gained a foothold after the company delivered a solid Q1 2024 earnings report 
Via MarketBeat
Exposures COVID-19

Performance

YTD
-8.35%
-8.35%
1 Month
+4.06%
+4.06%
3 Month
+22.61%
+22.61%
6 Month
-33.09%
-33.09%
1 Year
-38.12%
-38.12%

More News

Read More
How Is The Market Feeling About Novavax?
Via Benzinga
3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole
Via The Motley Fool
3 Biotech Stocks That Could Be Multibaggers in the Making: April Edition
Via InvestorPlace
Down 60% From Its 52-Week High, Is Novavax Stock a Buy?
Via The Motley Fool
(NVAX) - Analyzing Novavax's Short Interest
Via Benzinga
These Biotech Stocks Could Soar 120% and 295%, According to Wall Street
Via The Motley Fool
What's Going On With Novavax Stock Today?
Via Benzinga
Shah Capital nominates two highly qualified independent director candidates for Novavax
From Shah Capital
Via GlobeNewswire
Better Buy: Bluebird Bio Vs. Novavax
Via The Motley Fool
Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024?
Via InvestorPlace
1 Beaten-Down Stock That's Still Not Worth Buying
Via The Motley Fool
Is Novavax a Buy Now?
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
The Top 5 Analysts Ranked by Marketbeat and Stocks They Cover
Via MarketBeat
Topics Cannabis
Exposures Cannabis
1 Beaten-Down Stock to Buy and 1 to Avoid Like the Plague
Via The Motley Fool
Three Stocks With The Potential For A Short Squeeze In March
Via Talk Markets
7 Short-Squeeze Stocks That Could Send the Bears Into Panic-Mode
Via InvestorPlace
Two Beaten-Down Stocks That Could Soar 170% and 630%, Respectively, According to Wall Street
Via The Motley Fool
The Short List: 3 Meme Stock Battlegrounds to Keep on Your Radar
Via InvestorPlace
It’s Time! 3 Failing Biotech Stocks to Sell Right Now
Via InvestorPlace
Exit Alert: 3 Overhyped Stocks With Weak Fundamentals
Via InvestorPlace
1 of the Biggest Risks Facing Novavax Has Now Been Resolved: Is Now the Time to Buy the Stock?
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.